Señales en vivo de ATRA | Maximiza tus Ganancias con Getagraph.com

COMPRAR 107494 min ago

@ $0.771

Emitido: 14 feb 2024 @ 13:55

Retorno: -10.52%

Señal anterior: feb 13 - 15:34

Señal anterior: Vender

Retorno: -0.05 %

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 16:00):

Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States...

Stats
Volumen de hoy	526 741
Volumen promedio	2.69M
Capitalización de mercado	82.36M
EPS	$0 ( 2024-03-27 )
Próxima fecha de ganancias	( $-0.370 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.260
ATR14	$0.00200 (0.29%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-31	Fust Matthew K	Buy	150 000	Common Stock
2024-03-31	Heiden William K	Buy	150 000	Common Stock
2024-03-31	Roncarolo Maria Grazia	Buy	150 000	Common Stock
2024-03-31	Gallagher Carol Giltner	Buy	150 000	Common Stock
2024-03-31	Mallik Ameet	Buy	150 000	Common Stock

INSIDER POWER
70.32
Last 100 transactions
Buy: 8 350 944 \| Sell: 2 074 393

Volumen Correlación

Largo: -0.13 (neutral)

Corto: 0.82 (strong)

Signal:(52.538) Same movement expected

Atara Biotherapeutics Inc Correlación

10 Correlaciones Más Positivas
SRTS	0.965
CDXS	0.964
LGHL	0.959
ZD	0.957
ZYNE	0.952
RKDA	0.95
ATER	0.949
HNNA	0.948
NMTR	0.948
DYNT	0.946

10 Correlaciones Más Negativas
MCAA	-0.951
MSDA	-0.949
CITE	-0.945
DHAC	-0.944
AHRN	-0.942
LEGA	-0.942
ADAL	-0.942
FTAA	-0.94
PFTA	-0.939
ZING	-0.939

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Atara Biotherapeutics Inc Correlación - Moneda/Commodity

-0.60
( weak negative )

-0.57
( weak negative )

0.00
( neutral )

0.85
( strong )

Atara Biotherapeutics Inc Finanzas

Annual	2023
Ingresos:	$8.57M
Beneficio Bruto:	$-313 000 (-3.65 %)
EPS:	$-2.61

FY	2023
Ingresos:	$8.57M
Beneficio Bruto:	$-313 000 (-3.65 %)
EPS:	$-2.61

FY	2022
Ingresos:	$63.57M
Beneficio Bruto:	$49.01M (77.08 %)
EPS:	$-2.24

FY	2021
Ingresos:	$20.34M
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-3.63

Financial Reports:

No articles found.

Atara Biotherapeutics Inc

Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company is also developing next-generation CAR T immunotherapies for patients with hematologic malignancies and solid tumors, including ATA2271 and ATA3271 for mesothelin; and ATA2431 and ATA3219 for B-cell malignancies, as well as ATA188 for the treatment of multiple sclerosis. In addition, it develops ATA368 program for patients with human papillomavirus associated cancers. Atara Biotherapeutics, Inc. has a license agreement with Memorial Sloan Kettering Cancer Center; license, and research and development collaboration agreement with QIMR Berghofer Medical Research Institute; and strategic collaboration with H. Lee Moffitt Cancer Center, as well as Bayer AG for mesothelin-targeted CAR T-cell therapies for solid tumors. The company was incorporated in 2012 and is headquartered in South San Francisco, California.